Literature DB >> 29808171

Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis.

Daniel C Lee1,2, Monique E Hinchcliff3,4, Roberto Sarnari1, Madeline M Stark1, Jungwha Lee4,5, Kimberly Koloms4,5, Aileen Hoffmann3, Mary Carns3, Anjali Thakrar3, Kathleen Aren3, John Varga3, Alejandro Aquino1, James C Carr1,2,3,4,5, Brandon C Benefield1, Sanjiv J Shah1,2.   

Abstract

PURPOSE: To evaluate the utility of cardiac magnetic resonance (CMR) T1 mapping in early systemic sclerosis (SSc) and its association with skin score.
METHODS: Twenty-four consecutive patients with early SSc referred for cardiovascular evaluation and 12 controls without SSc were evaluated. All patients underwent cine, T1 mapping, and late gadolinium enhanced (LGE) CMR imaging. T1 mapping indices were compared between SSc patients and controls (extracellular volume fraction [ECV], gadolinium partition coefficient [λ], pre-contrast T1, and post-contrast T1). The association between T1 mapping parameters and the modified Rodnan skin score (mRSS) was determined.
RESULTS: There were no significant differences in cardiac structure/function between SSc patients and controls on cine imaging, and 8/24 (33%) SSc patients had evidence of LGE (i.e., focal myocardial fibrosis). Of the T1 mapping parameters (indices indicative of diffuse myocardial fibrosis), ECV differentiated SSc patients from controls the best, followed by λ, even when the eight SSc patients with LGE were excluded. ECV had a sensitivity and specificity of 75% and 75% for diffuse myocardial fibrosis (optimal abnormal cut-off value of >27% [area under ROC curve=0.85]). In the 16 patients without evidence of LGE, each of the 4 CMR T1 mapping parameters (ECV, λ, Pre-T1 and Post-T1) correlated with mRSS (R=0.51-0.65, P=0.007-0.043), indicating a correlation between SSc cardiac and skin fibrosis.
CONCLUSIONS: The four T1 mapping indices are significantly correlated with mRSS in patients with early SSc. Quantification of diffuse myocardial fibrosis using ECV should be considered as a marker for cardiac involvement in SSc clinical studies.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Extracellular Volume Fraction; Myocardial fibrosis; Scleroderma; Skin fibrosis; Systemic sclerosis; T1 mapping; modified Rodnan skin score

Year:  2018        PMID: 29808171      PMCID: PMC5969530          DOI: 10.1177/2397198318762888

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  44 in total

Review 1.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

Review 2.  Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.

Authors:  Christophe Meune; Olivier Vignaux; André Kahan; Yannick Allanore
Journal:  Arch Cardiovasc Dis       Date:  2009-11-28       Impact factor: 2.340

3.  Motion correction for myocardial T1 mapping using image registration with synthetic image estimation.

Authors:  Hui Xue; Saurabh Shah; Andreas Greiser; Christoph Guetter; Arne Littmann; Marie-Pierre Jolly; Andrew E Arai; Sven Zuehlsdorff; Jens Guehring; Peter Kellman
Journal:  Magn Reson Med       Date:  2011-08-29       Impact factor: 4.668

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

6.  Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.

Authors:  Valentina O Puntmann; David D'Cruz; Zachary Smith; Ana Pastor; Peng Choong; Tobias Voigt; Gerry Carr-White; Shirish Sangle; Tobias Schaeffter; Eike Nagel
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-12       Impact factor: 7.792

7.  Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.

Authors:  Franck Thuny; Daniel Lovric; Frédéric Schnell; Cyrille Bergerot; Laura Ernande; Vincent Cottin; Geneviève Derumeaux; Pierre Croisille
Journal:  Radiology       Date:  2014-01-15       Impact factor: 11.105

8.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

9.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.

Authors:  Songtao Liu; Jing Han; Marcelo S Nacif; Jacquin Jones; Nadine Kawel; Peter Kellman; Christopher T Sibley; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-28       Impact factor: 5.364

10.  Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.

Authors:  Christopher A Miller; Josephine H Naish; Paul Bishop; Glyn Coutts; David Clark; Sha Zhao; Simon G Ray; Nizar Yonan; Simon G Williams; Andrew S Flett; James C Moon; Andreas Greiser; Geoffrey J M Parker; Matthias Schmitt
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-03       Impact factor: 7.792

View more
  4 in total

1.  Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.

Authors:  Raluca B Dumitru; Lesley-Anne Bissell; Bara Erhayiem; Graham Fent; Ananth Kidambi; Peter Swoboda; Giuseppina Abignano; Helena Donica; Agata Burska; John P Greenwood; John Biglands; Francesco Del Galdo; Sven Plein; Maya H Buch
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

Review 2.  Heart Failure in Chronic Infectious and Inflammatory Conditions: Mechanistic Insights from Clinical Heterogeneity.

Authors:  Nour Beydoun; Matthew J Feinstein
Journal:  Curr Heart Fail Rep       Date:  2022-07-15

3.  State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.

Authors:  Graham Dinsdale; Sarah Wilkinson; Jack Wilkinson; Tonia L Moore; Joanne B Manning; Michael Berks; Elizabeth Marjanovic; Mark Dickinson; Ariane L Herrick; Andrea K Murray
Journal:  Microvasc Res       Date:  2020-04-19       Impact factor: 3.514

Review 4.  The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.

Authors:  Ioana Bratoiu; Alexandra Maria Burlui; Anca Cardoneanu; Luana Andreea Macovei; Patricia Richter; Gabriela Rusu-Zota; Ciprian Rezus; Minerva Codruta Badescu; Andreea Szalontay; Elena Rezus
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.